wegovy hers - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Bloomberg on MSN · 2h

Novo exits Hims & Hers partnership, citing ‘deceptive marketing’ concerns

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is using “deceptive marketing” to sell copycat versions of its obesity blockbuster Wegovy.

13m

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

16hon MSN

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...

1don MSN

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Novo Nordisk said Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs” under the ...

21hon MSN

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...

Yahoo Finance5h

Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers?

Novo Nordisk NVO ended its collaboration agreement with telehealth company Hims & Hers Health HIMS to offer its blockbuster obesity drug Wegovy (semaglutide) at a discounted price to cash-paying ...

StockStory.org on MSN1d

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker ...

2hon MSN

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results